User:Hmandeville/sandbox

W. HARRY 13 MANDEVILLE III (W. HARRY II 12 WILLIAM HARRY 11 WILLIAM HOWARD 10 JOHN DRAKE II 9 JOHN DRAKE 8 JOHN 7 CORNELIUS 6 DAVID 5 HENDRICK 4 YELLIS 3 Rev JOHANNES 2 Dr. MICHAEL JANSZ 1) was born in Tulsa, OK on Aug. 3, 1949 and moved to Arvada, CO with his parents in the summer of 1960. In Tulsa he attended Barnard Elementary School and in Colorado he attended Fitzsimmons Elementary School (6th grade only), 7th Grade Jr. High School, North Arvada Junior High School 8 th and 9 th grades) and Arvada West High School, graduating in 1967.

He attended college at Colorado School of Mines in Golden Colorado, graduating in 1971 with a B.S. degree in Mineral Engineering Chemistry. After Mines he attended Massachusetts Institute of Technology, where he received a Ph.D. degree in Organic Chemistry in May 1975 under the tutelage of Prof. George McClelland Whitesides.

He married Susan Marie (Turner) on Aug 9, 1975. Susan was born in Syracuse, NY and lived in New Mexico for the first five years of her life. In 1954, her father was transferred by General electric to Massachusetts. She lived in Melrose, MA until her marriage to Harry.

Harry’s first job was with Hoffmann-La Roche company in Nutley, NJ. They rented half of a two-family home in Clifton, NJ for three years and then bought their first house at 440 Lafayette Ave. in Wyckoff, NY in 1978. Harry worked for Roche for 10 years and moved to Hyperion Catalysis International in Massachusetts. They moved to 7 Pillings Pond Road in Lynnfield, MA, where they reside today. After two years with Hyperion, Harry changed jobs again and moved to Waters Chromatography, a division of Millipore Corp., where he worked for 4 years. After Waters, Harry became the first employee of GelTex Corp., a company founded by George Whitesides, among others.

GelTex, a pharmaceutical company, became very successful under Harry’s leadership. It introduced two new drugs, Renagel and Welchol, both of which Harry co-invented. Renagel was for the treatment of hyperphosphatemia in renal failure patients and Welchol was for the treatment of hypercholesterolemia. GelTex was purchased by Genzyme Corp. in 2000 for $1.3 billion.

After Genzyme, where Harry was a Sr. Vice President of Research, he moved to Peptimmune for about four years where he worked on the development of a drug he helped invent at Genzyme and then successfully licensed to Peptimmune. The drug did not succeed and Harry retired from Peptimmune on Feb. 16, 2007.

Interestingly, Harry’s father developed end-stage renal disease in 1998 and went on dialysis. He was a candidate for treatment with Renagel and became one of the very first patients treated with it in November of 1998. This fact, the invention of drug by the son for use by his father was not lost on the media. Paul Harvey loved stories about his old friends at Tulsa Central and he jumped on this one. Thus, Harry and his father became the subjects of one of Paul Harvey’s Rest of the Story vignettes.

Harry, as a result of very successful career at GelTex, received many awards. Included are the American Chemical Society Award for Team Innovation, 2005. Colorado School of Mines Distinguished Achievement Medal, 2004. Colorado School of Mines Chemistry Department Visiting Committee, 2003. Colorado School of Mines Distinguished Alumni Lecturer, 2002. American Chemical Society, Northeast Region, Industrial Innovation Award, 2001. National Kidney Foundation of Northern California, Champion of Hope Award, 2001. American Chemical Society, Polymer Chemistry Division, Award for Industrial Polymer Chemistry, 2000. R&D 100 Award for Renagel Capsules. Awarded by R&D magazine, 1999.

Harry and Susan’s children are: i. Jennie Marie, born Sept 28, 1979 ii Rebecca Kate, born May 16, 1984.